| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $24,318,765 ) |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 003 | 5 | NIH | 9/8/2025 | $64,322 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | F31NS139617 | Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | 000 | 1 | NIH | 8/13/2025 | $45,724 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 003 | 4 | NIH | 6/25/2025 | $328,637 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 001 | 2 | NIH | 8/16/2025 | $183,548 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 000 | 2 | NIH | 8/7/2025 | $401,669 |
| | 2025 | 2025 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 000 | 4 | NIH | 11/21/2024 | $359,442 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 001 | 4 | NIH | 7/23/2025 | $39,938 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 003 | 2 | NIH | 6/20/2025 | $63,942 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 002 | 2 | NIH | 4/24/2025 | $719,342 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG077780 | Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | 000 | 3 | NIH | 3/25/2025 | $548,093 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG077780 | Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | 001 | 3 | NIH | 6/18/2025 | $48,720 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01HL156891 | Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor LKB1 in Exosomes | 000 | 4 | NIH | 7/16/2025 | $417,885 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS115815 | A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury | 000 | 5 | NIH | 4/21/2025 | $552,243 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 002 | 5 | NIH | 8/18/2025 | $650,303 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 002 | 5 | NIH | 8/18/2025 | $137,941 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | F31NS139617 | Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | 001 | 1 | NIH | 8/13/2025 | $0 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | OT2NS136939 | Access for All in ALS (ALL ALS) West Clinical Coordinating Center | 001 | 1 | NIH | 8/14/2025 | $20,235,572 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 001 | 3 | NIH | 12/18/2024 | -$483,637 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 000 | 3 | NIH | 10/31/2024 | $170,777 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS138528 | Endothelial complement C3a receptor mediated cerebral injury in a murine stroke model. | 000 | 1 | NIH | 9/9/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 000 | 1 | NIH | 11/13/2024 | -$802,017 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 001 | 1 | NIH | 11/15/2024 | $802,017 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R61NS127268 | Diffusion MRI Biomarkers of Peripheral Nerve Trauma | 000 | 2 | NIH | 8/25/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 000 | 4 | NIH | 7/11/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 000 | 4 | NIH | 7/11/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 000 | 4 | NIH | 7/11/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 001 | 4 | NIH | 8/14/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 001 | 4 | NIH | 8/14/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 001 | 4 | NIH | 8/14/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES021488 | Imaging Biomarkers of Neurotoxicity in Welders | 000 | 10 | NIH | 7/29/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | P01AG014449 | Neurobiology of Mild Cognitive Impairment in the Elderly | 001 | 26 | NIH | 2/20/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | P01AG014449 | Neurobiology of Mild Cognitive Impairment in the Elderly | 000 | 26 | NIH | 10/17/2024 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | OT2NS136939 | Access for All in ALS (ALL ALS) West Clinical Coordinating Center | 000 | 1 | NIH | 3/27/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | GE153343 | Community Project Funding/Congressionally Directed Spending - Non-Construction | 02 | 1 | HRSA | 3/12/2025 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | GE153343 | Community Project Funding/Congressionally Directed Spending - Non-Construction | 01 | 1 | HRSA | 10/23/2024 | $0 |
| | 2025 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 002 | 3 | NIH | 12/20/2024 | $483,637 |
| | 2025 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG073212 | Repurposing Siponimod for Alzheimer's Disease | 001 | 3 | NIH | 8/8/2025 | $0 |
| | 2025 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG073212 | Repurposing Siponimod for Alzheimer's Disease | 000 | 3 | NIH | 4/16/2025 | $0 |
| | 2025 | 2022 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01CA213158 | Establishing the Validity of Brain Tumor Perfusion Imaging | 000 | 6 | NIH | 1/10/2025 | -$315,116 |
| | 2025 | 2022 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | U24NS107204 | Barrow Neurological Institute application to become a NeuroNEXT site. | 000 | 5 | NIH | 3/28/2025 | -$117,353 |
| | 2025 | 2022 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG057708 | Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ Dementia | 000 | 4 | NIH | 4/7/2025 | $0 |
| | 2025 | 2021 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | UG3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 000 | 2 | NIH | 10/31/2024 | -$170,777 |
| | 2025 | 2021 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01ES026891 | Manganese-Induced Neurotoxic Effects Research in South Africa | 000 | 6 | NIH | 2/25/2025 | $0 |
| | 2025 | 2020 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01DA042749 | Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine Addiction | 000 | 4 | NIH | 10/17/2024 | -$46,087 |
|
| Issue Date FY: 2024 ( Subtotal = $26,127,675 ) (Continued on the next page) |
| | 2024 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | OT2NS136939 | Access for All in ALS (ALL ALS) West Clinical Coordinating Center | 005 | 1 | NIH | 9/20/2024 | $14,234,367 |
| | 2024 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 000 | 1 | NIH | 8/30/2024 | $601,159 |
| | 2024 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 000 | 3 | NIH | 9/23/2024 | $483,637 |
| | 2024 | 2024 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 000 | 1 | NIH | 7/30/2024 | $802,017 |
|
